
Overview
Axel Van Der Gucht practices in Creteil, France. Mr. Van Der Gucht is rated as an Elite expert by MediFind in the treatment of Macrophagic Myofasciitis. His top areas of expertise are Macrophagic Myofasciitis, Cardiac Amyloidosis, Myositis, and Primary Amyloidosis.
His clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Macrophagic Myofasciitis.
Locations
Nancy, 54000, France
Vandoeuvre-les-nancy, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Macrophagic MyofasciitisMr. Van Der Gucht isElite. Learn about Macrophagic Myofasciitis.
- Advanced
- Cardiac AmyloidosisMr. Van Der Gucht isAdvanced. Learn about Cardiac Amyloidosis.
- MyositisMr. Van Der Gucht isAdvanced. Learn about Myositis.
- Experienced
- Breast Enlargement In MalesMr. Van Der Gucht isExperienced. Learn about Breast Enlargement In Males.
- Familial Transthyretin AmyloidosisMr. Van Der Gucht isExperienced. Learn about Familial Transthyretin Amyloidosis.
- Follicular LymphomaMr. Van Der Gucht isExperienced. Learn about Follicular Lymphoma.
- GliomaMr. Van Der Gucht isExperienced. Learn about Glioma.
- Gliomatosis CerebriMr. Van Der Gucht isExperienced. Learn about Gliomatosis Cerebri.
- Hodgkin LymphomaMr. Van Der Gucht isExperienced. Learn about Hodgkin Lymphoma.